Catheter Precision (NYSEAMERICAN:VTAK) Stock Price Up 2.4% – Should You Buy?

Catheter Precision, Inc. (NYSEAMERICAN:VTAK)’s stock price shot up 2.4% during mid-day trading on Wednesday . The stock traded as high as $0.36 and last traded at $0.34. 82,934 shares changed hands during trading, a decline of 81% from the average session volume of 427,168 shares. The stock had previously closed at $0.34.

Catheter Precision Stock Up 2.4 %

The company has a current ratio of 0.66, a quick ratio of 0.65 and a debt-to-equity ratio of 0.12.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Catheter Precision stock. Warberg Asset Management LLC lifted its stake in shares of Catheter Precision, Inc. (NYSEAMERICAN:VTAK) by 362.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 310,164 shares of the company’s stock after buying an additional 243,164 shares during the period. Warberg Asset Management LLC owned approximately 3.51% of Catheter Precision worth $140,000 at the end of the most recent quarter. Institutional investors own 20.34% of the company’s stock.

Catheter Precision Company Profile

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.